Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
DOI: https://doi.org/10.2478/ahem-2022-0047 | Journal eISSN: 1732-2693
Language: English
Page range: 333 - 338
Submitted on: Jan 3, 2022
Accepted on: May 11, 2022
Published on: Aug 9, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2022 Tomasz Jarzembowski, Agnieszka Daca, Wiesław J. Cubała, Marek Bronk, Łukasz Naumiuk, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.